Nektar Therapeutics
Clinical trials sponsored by Nektar Therapeutics, explained in plain language.
-
New drug trial aims to regrow hair for people with severe alopecia
Disease control OngoingThis study is testing whether an experimental drug called rezpegaldesleukin can help regrow hair in adults with severe to very severe alopecia areata, an autoimmune condition that causes hair loss. About 94 participants will receive either the drug or a placebo for 36 weeks to se…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New injection shows promise for controlling severe eczema
Disease control OngoingThis study is testing whether an investigational drug called rezpegaldesleukin can help control moderate-to-severe eczema (atopic dermatitis) in adults. About 400 participants will receive either the drug or a placebo injection to compare effectiveness. The main goal is to see ho…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC